A Case Report of Diabetic Ketoacidosis Associated with Multiple Risk Factors Including Dapagliflozin Use

Posted on

Sodium-glucose linked transporter 2 (SGLT2) inhibitors are a new class of antihyperglycemic agents that inhibit renal glucose reabsorption his group of medications got more popular in diabetic management as it help to control the blood sugar level and it induce weight loss. …to know more please visit…http://www.scitechnol.com/abstract.php?abstract_id=5206


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s